Literature DB >> 22880886

The value of the metabolic syndrome concept in elderly adults: is it worth less than the sum of its parts?

Katherine Samaras1, John Crawford, Bernard T Baune, Lesley V Campbell, Evelyn Smith, Ora Lux, Henry Brodaty, Julian N Trollor, Perminder Sachdev.   

Abstract

OBJECTIVES: To determine whether the metabolic syndrome (MetS) or its components were more closely associated with disease states and inflammation in elderly adults.
DESIGN: Sydney Memory and Ageing Study. Cross-sectional, observational cohort.
SETTING: Population-derived, community-dwelling elderly adults. PARTICIPANTS: Nine hundred thirty individuals aged 70 to 90. MEASUREMENTS: Age- and sex-adjusted odds ratios (ORs) for disease states; fasting circulating inflammatory markers and oxidative metabolism byproducts.
RESULTS: MetS was associated with diabetes mellitus (OR = 4.1, P < .001) and bowel cancer (OR = 9.1, P = .03) but not in analyses that controlled for component conditions. Models containing component conditions had the strongest associations with heart disease. Disease associations were improved after addition of component conditions to the MetS model. The reverse did not hold: disease associations were not improved when MetS was added to the components model. Low high-density lipoprotein cholesterol (HDL-C) was independently associated with myocardial infarction (OR = 2.32) and angina pectoris (OR = 2.59) (both P < .008). Waist circumference was independently associated with cancer (OR = 1.82, P = .008). Although MetS was associated with higher C-reactive protein, vascular cell adhesion molecule, interleukin-6, amyloid A, homocysteine, and malondialdehyde, it explained less than half of the variance of models containing its components.
CONCLUSION: The observation that MetS is associated with disease states and markers of circulating inflammation in the elderly is explained mainly by abdominal obesity and low HDL-C. Longitudinal data will further clarify these cross-sectional findings that MetS appears to be less than the sum of its parts in elderly adults.
© 2012, Copyright the Authors Journal compilation © 2012, The American Geriatrics Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22880886     DOI: 10.1111/j.1532-5415.2012.04105.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  6 in total

1.  Prevalence of metabolic syndrome and its association with physical capacity, disability, and self-rated health in Lifestyle Interventions and Independence for Elders Study participants.

Authors:  Anda Botoseneanu; Walter T Ambrosius; Daniel P Beavers; Nathalie de Rekeneire; Stephen Anton; Timothy Church; Sara C Folta; Bret H Goodpaster; Abby C King; Barbara J Nicklas; Bonnie Spring; Xuewen Wang; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2015-01-30       Impact factor: 5.562

2.  The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study.

Authors:  Katherine Samaras; Helen L Lutgers; Nicole A Kochan; John D Crawford; Lesley V Campbell; Wei Wen; Melissa J Slavin; Bernard T Baune; Darren M Lipnicki; Henry Brodaty; Julian N Trollor; Perminder S Sachdev
Journal:  Age (Dordr)       Date:  2014-01-09

3.  High polygenic risk score for exceptional longevity is associated with a healthy metabolic profile.

Authors:  Mary Revelas; Anbupalam Thalamuthu; Anna Zettergren; Christopher Oldmeadow; Jenna Najar; Nazib M Seidu; Nicola J Armstrong; Carlos Riveros; John B Kwok; Peter R Schofield; Julian N Trollor; Margda Waern; Margaret J Wright; Henrik Zetterberg; David Ames; Kaj Belnnow; Henry Brodaty; Rodney J Scott; Ingmar Skoog; John R Attia; Perminder S Sachdev; Karen A Mather
Journal:  Geroscience       Date:  2022-08-16       Impact factor: 7.581

Review 4.  Adipokine Dysregulation and Insulin Resistance with Atherosclerotic Vascular Disease: Metabolic Syndrome or Independent Sequelae?

Authors:  Mohan Satish; Shailendra K Saxena; Devendra K Agrawal
Journal:  J Cardiovasc Transl Res       Date:  2019-03-05       Impact factor: 3.216

5.  Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease.

Authors:  Marion C Devers; Stewart Campbell; David Simmons
Journal:  BMJ Open Diabetes Res Care       Date:  2016-04-25

6.  Plasminogen Activator Inhibitor-1 and Diagnosis of the Metabolic Syndrome in a West African Population.

Authors:  Nuri Kodaman; Melinda C Aldrich; Rafal Sobota; Folkert W Asselbergs; Nancy J Brown; Jason H Moore; Scott M Williams
Journal:  J Am Heart Assoc       Date:  2016-10-03       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.